Approval · Notice of Compliance 3829 · 1997
GEMFIBROZIL: Notice of Compliance 3829
Issued April 24, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3829
- Date
- April 24, 1997
- Company
- Prempharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihyperlipidemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEMFIBROZIL | 02230742 | — |
| GEMFIBROZIL | 02230743 | — |
Medicinal ingredients
- GEMFIBROZIL 300 MG per CAP
- GEMFIBROZIL 600 MG per TAB